Talk:Janet Lane-Claypon
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Biography. For more information, visit the project page. | ||
| B | This article has been rated as B-Class on the project's quality scale. [FAQ] | ||
 |
This article is supported by the Science and academia work group. | ||
This is a fascinating article but some of the material is plagiarized. For example, this entire paragraph is taken verbatim from the Breast Cancer Action newsletter, without attribution: "Woven through all of these reports are Lane-Claypon’s scrupulous and prescient concerns about the drawbacks and uncertainties that her own methodology exposed. Sidebar discussions reveal an extraordinarily rigorous and subtle intelligence at work. In the end-results study just mentioned, Lane-Claypon acknowledges the difficulties involved in deriving an accurate staging of the disease (in the days before routine diagnostic biopsies). She understood that differences in access to health care (and hence to surgical treatment) would influence survival results. She recognized the problems of bias created by limiting the study to survivors and by relying on the recall of breast cancer patients themselves rather than observing (with greater neutrality and potentially greater accuracy) the experience of newly diagnosed women going through treatment and beyond. Finally, in reviewing the family histories of her cases, she anticipated the role that genes might play in the development of breast cancer. 'There appear to be some families,' she wrote, 'in which for reasons not certain at present, cancer plays havoc with the members, and there is (some) slight evidence in some instances that it attacks the same organs.'"
Sbartell 02:20, 28 June 2007 (UTC)
